FUNDAMENTALS · Fundamentals · US Healthcare

Outset Medical (OM) Fundamentals 2026 — Revenue Analysis | SniperIQ

Outset Medical (OM) is a US-listed Healthcare company in Medical - Devices with a market capitalization of $78M, trading at $4.21 on the NASDAQ. This SniperIQ fundamentals page covers Outset Medical's valuation, profitability (net margin -63.7%), revenue (

19M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap$78M
Net Margin-63.7%
Revenue (FY25)
19M

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Outset Medical's market cap?

Outset Medical (OM) has a market capitalization of approximately $78M, trading at $4.21 on the NASDAQ. Market cap moves with the live share price.

What is Outset Medical's P/E ratio?

Outset Medical's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.7x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Outset Medical?

Outset Medical runs a net profit margin of -63.7%, a gross margin of 40.6%, and an operating margin of -57.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Outset Medical generate?

Outset Medical reported revenue of

19M for fiscal year 2025, with net income of -$82M and earnings per share (EPS) of -5.37. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Outset Medical pay a dividend?

Outset Medical does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Outset Medical financially healthy?

Outset Medical carries a debt-to-equity ratio of 0.91x and a current ratio of 6.29x, with a market beta of 1.94. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Outset Medical a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Outset Medical (OM) the key facts are: market cap $78M, revenue

19M, 52-week range 3-19.6. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Outset Medical's full fundamentals live

Get Outset Medical's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Comfort Gloves (2127) fundamentals · Heron Therapeutics (HRTX) fundamentals · Gain Therapeutics (GANX) fundamentals · Arovella Therapeutics (ALA) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons